News
The company's computer vision technology tracks supply and implant usage in hospital operating and procedural rooms.
The company will use the funds to expand operations in the EU and U.S.
The company will use the funds to grow its team, expedite commercial deployments with pharma companies and enhance Willis, its new clinical outcome assessment platform.
The company will use its platform to track and analyze Team USA athletes' health, training and nutrition data, and collect data on fans both at home and attending events.
Marcel Botha, cofounder and CEO of 10XBeta, warns that President Trump's tariffs may jeopardize the quality and safety of medical innovations and hinder patient care.
The WHA also approved the next phase of digital health strategy for 2028 to 2033.
The orchestrator includes customizable, multimodal AI agents to streamline oncology workflows like tumor boards and improve clinical decision-making.
Indian e-clinic startup CureBay also looks to expand its rural network.
The funds will be used to help the company expand into the employer and health plan markets and speed up the development of its AI technology for providers and members.
The company began trading on the NYSE today under the ticker symbol HNGE, opening at $39.25, up 23% from its IPO price of $32, and closing at $37.56 per share.